Detailed data on Biogen’s resurrected Alzheimer’s drug raise more questions than answers
(By Rebecca Robbins and Matthew Herper for STAT) SAN DIEGO — Biogen (BIIB) on Thursday presented detailed data making a
Read More
FDA
No Safety Switch: How Lax Oversight Of Electronic Health Records Puts Patients At
(By Fred Schulte and Erika Fry, Fortune and Kaiser Health News) In fall 2009, several dozen of the best minds
Read MoreProblems with drugs can take years to discover; more caution is warranted
According to a recent Kaiser Health News analysis, some of the newest most expensive brand-name medicines have been plagued by
Read MoreFDA report has three recommendations to reduce drug shortages
After a year of study, the FDA released its report Drug Shortages: Root Causes and Potential Solutions stating with the
Read MoreHidden FDA Reports Detail Harm Caused By Scores Of Medical Devices
Dr. Douglas Kwazneski was helping a Pittsburgh surgeon remove an appendix when something jarring happened. The surgical stapler meant to
Read MorePresidential candidates aren’t talking about drug shortages. They should be
(By Patrick Skerrett for STAT) In the conclusion of her recently published book, “Bottle of Lies,” Katherine Eban briefly notes
Read MoreNovartis was aware of manipulation of data supporting gene therapy approval, FDA says
(By Adam Feuerstein for STAT) AveXis, the gene therapy subsidiary of Swiss pharma giant Novartis (NVS), was aware of “data
Read MoreTrump Administration ‘Open For Business’ On Drug Imports From Canada
(By Phil Galewitz for Kaiser Health News) A year after calling proposals allowing Americans to import cheaper drugs from Canada
Read MoreFDA approves Rituxan biosimilar
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune
Read MoreFDA approves 1st Lyrica generics
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved several new generics of Lyrica, a brand-name drug manufactured by Pfizer
Read More